drugset
drugset / Trial / NCT05657834

Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects

NCT05657834 ↗

Phase 1 Completed 8 enrolled Sagimet Biosciences Inc.
NaSingle-groupOpen-labelOther

Summary

A Phase 1, Open-label Study of the absorption, metabolism, and excretion of a single oral dose of \[14C\]TVB-2640 healthy male subjects.

Timeline

Start
2022-11-21
Primary completion
2022-12-21
Completion
2022-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Denifanstat Small molecule 50 mg Oral

Indications

No indication recorded.